Pediatr. praxi. 2010;11(5):292-294

Treatment of steroid-sensitive nephrotic syndrome in children

MUDr.Pavel Geier, Ph.D., doc.MUDr.Janusz Feber
Division of Nephrology, Children’,s Hospital of Eastern Ontario, Ottawa, Canada

Review article describing current insights into the treatment of steroid-sensitive nephrotic syndrome in children. Treatment regimens

based on data from adequately powered randomized controlled trials were stressed out.

Keywords: steroid-sensitive nephrotic syndrome, prednison, cyclophosphamide, cyclosporine A

Published: October 15, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Geier P, Feber J. Treatment of steroid-sensitive nephrotic syndrome in children. Pediatr. praxi. 2010;11(5):292-294.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hodson EM, Alexander SI, Graf N. Steroid-Sensitive Nephrotic Syndrome. In Geary DF, Schaefer F. Comprehensive Pediatric Nephrology. Mosby, Philadelphia. 2008: 239-256. Go to original source...
    2. Vogt BA, Avner ED. Nephrotic syndrome. In Kliegman RM, Behrman RE, Jenson HB, Stanton BMD (eds). Nelson Textbook of Pediatrics. Saunders, Philadelphia. 2007: 2190-2194.
    3. International Study of Kidney Disease in Children: The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J Pediatr 1981; 98: 561-564. Go to original source... Go to PubMed...
    4. Geier P, Feber J. Nefrotický syndrom. In Janda J. (ed). Dětská nefrologie. Galén, Praha 2006: 151-165.
    5. Brodehl J. The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies. Eur J Pediatr 1991; 150: 380-387. Go to original source... Go to PubMed...
    6. Bargman JM. Management of minimal lesion glomerulonephritis: Evidence-based recomendations. Kidney Int 1999; 55: S3-16. Go to original source... Go to PubMed...
    7. Hodson EM, Willis NS, Craig JC. Cortikosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 2007; 17(4): CD001533. Go to original source... Go to PubMed...
    8. MacHardy N, Miles PV, Massengill SF, et al. Management patterns of childhood-onset nephrotic syndrome. Pediatr Nehprol 2009; 24: 2193-2201. Go to original source... Go to PubMed...
    9. Vande Walle JGJ, Donckerwolcke RA. Pathogenesis of edema formation in the nephrotic syndrome. Pediatr Nephrol 2001; 16: 283-293. Go to original source... Go to PubMed...
    10. Barratt TM, Soothill JF. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet 1970; 2(7671): 479-482. Go to original source... Go to PubMed...
    11. Cammas B, Harambat J, Bertholet-Thomas A, et al. Longterm effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrol Dial Transplant 2010; doi: 10.1093/ndt/gfq405. Go to original source... Go to PubMed...
    12. Latta K, von Schnakenburg Ch, Ehrich JHH. A metaanalysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 2001; 16: 271-282. Go to original source... Go to PubMed...
    13. Hodson EM, Willis NS, Craig JC. Non-corticosteroid treatment for nephrotic syndrome in children. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD002290. Go to original source...
    14. Ponticelli C, Edefonti A, Ghio I, et al. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Nephrol Dial Transplant 1993; 8: 1326-1332.
    15. Dorresteijn EM, Kist-van Holthe JE, Levtchenko EN, et al. Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome. Pediatr Nephrol 2008; 23: 2013-2020. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.